Bridgebio Pharma (BBIO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec17

BridgeBio Pharma insiders sold $2,239,902 worth of shares

09:13

Dec16

Bridgebio Pharma CEO Exercises and Returns Shares

23:32

Dec15

Mani Foroohar Reiterates Buy Rating on BridgeBio Pharma

15:44

Dec11

HighVista Strategies LLC Increases Holdings in BridgeBio Pharma

12:29

Dec10

BridgeBio Launches Clinical Trial of BBO-10203 for Advanced Solid Tumors

21:05

Maricel Apuli Reports Sale of BridgeBio Pharma Inc. Common Stock

12:54

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 120.7 M, Net Income -182.74 M, EPS -0.9525

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 110.57 M, Net Income -181.9 M, EPS -0.9547

Apr29

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 116.63 M, Net Income -167.42 M, EPS -0.8804

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change